The pharmacodynamics and pharmacokinetics of different regimens and doses of esomeprazole in Chinese volunteers

Trial Profile

The pharmacodynamics and pharmacokinetics of different regimens and doses of esomeprazole in Chinese volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Sep 2013

At a glance

  • Drugs Esomeprazole (Primary)
  • Indications Bleeding ulcer; Gastro-oesophageal reflux; Helicobacter infections; NSAID-induced ulcer; Reflux oesophagitis; Zollinger-Ellison syndrome
  • Focus Pharmacodynamics; Pharmacogenomic
  • Most Recent Events

    • 20 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top